![a photo of a home AIDS test](https://www.uc.edu/news/articles/2023/02/n21150408/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1677080370584.jpg)
Local 12: Report: Person was 'cured' of HIV, but a local doctor says treatment is dangerous
UC expert has concerns about stem cell transplants
New research published in the Nature Medicine journal says a 53-year-old German man is now clear of HIV after a procedure that replaced his bone marrow cells with HIV-resistant stem cells from a donor. He is just the third person to be cured of HIV.
WKRC-TV, Local 12, interviewed Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the University of Cincinnati College of Medicine, who was at the scientific meeting in Seattle where this research was released.
"I do hope in my professional lifetime will be able to see him the situation where we can cure a disease like HIV,” said Fichtenbaum. "Every year, we get a little bit closer to a better answer.”
/content/dam/uc/news/ahc-public-relations/medicine/fichtenbaum-lab-folder.jpg/Photo/Colleen Kelley/UC Marketing + Brand
While the news about the German patient is exciting, Fichtenbaum knows it doesn't do much for the average person living with the virus.
"It’s very important, it gives us hope, but it’s not a scalable cure that can be down at your local pharmacy tomorrow," said Fichtenbaum.
That is mostly because of how specific the patient's health condition is and because Fichtenbaum says operations like stem cell transplants are extremely dangerous.
"We have tried this several times and it’s failed because bone marrow transplant transplants, stem cell transplants are dangerous, and these are mostly used in individuals who have cancer,” said Fichtenbaum.
Lead photo/Aaron Ufumeli/EPA-EFE
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Local 12: Music creation's impact on the brain after cancer
August 4, 2021
UC researchers launched a new study looking treating a common brain problem that results after therapy for cancer.
WLWT: COVID-19 vaccine distribution in Ohio
January 11, 2021
COVID-19 vaccine providers across Ohio will soon get better guidance about the next steps for getting shots into arms. Brett Kissela, MD, spoke to WLWT-TV, Channel 5 and said the benefits of the vaccine outweigh any potential side effects.
What's Happening in Health: RNA treatment for brain cancer
May 18, 2021
UC's Daniel Pomeranz Krummel, PhD, discusses new brain cancer research with Liz Bonis on Local 12's What's Happening in Health program.
'I'm a believer': UC dean for research takes next step in COVID-19 trial
January 8, 2021
Brett Kissela, MD, senior associate dean for clinical research at the UC College of Medicine and chief of research services at UC Health, learned he received the placebo in the Moderna vaccine clinical trial. He then received the real vaccine to show that he believes in the science.
MedPage Today: Preop chemotherapy misses mark in pancreatic cancer
January 21, 2021
UC research, published in JAMA Oncology, shows that chemotherapy before surgery for some pancreatic cancer patients may not improve survival rates.
COVID-19 Conversations Podcast: Participation in vaccine trial
December 17, 2020
UC's Brett Kissela, MD, discusses participating in the Moderna vaccine trial on an African Alliance podcast.
WVXU: Does your spinal fluid show if you have a tumor?
November 9, 2020
University of Cincinnati researchers are starting a clinical trial to determine if they can detect brain cancer in spinal fluid.
US News & World Report: Immunotherapy and cancer, COVID-19
July 21, 2020
National media outlets report on new UC findings that show immunotherapy will not worsen complications for patients who have cancer and COVID-19.
Drugs.com: Effect of cancer treatment on COVID-19 mortality
September 22, 2020
Drugs.com covers UC research looking at mortality in patients with cancer and COVID-19.
WVXU: Certain cancer treatments & COVID-19 could lead to death
September 22, 2020
WVXU reports on a University of Cincinnati study showing cancer patients undergoing a combination of chemotherapy and immunotherapy one to three months before a COVID-19 diagnosis have a greater risk of death than patients who haven't undergone cancer treatment in the past year.